\-\ Texto\\:\\ \ \(0\)\
\-\ well\\-appearing\\ woman\\ in\\ no\\ acute\\ distress\\.\\ \\ neurologically\\,\\ she\\ was\\ alert\\ and\\ oriented\\.\\ \\ pupils\\ were\\ equal\\ and\\ reactive\\.\\ \\ \\ extraocular\\ movements\\ were\\ intact\\.\\ \\ no\\ visual\\ field\\ deficits\\ were\\ revealed\\.\\ \\ she\\ moved\\ all\\ extremities\\ symmetrically\\.\ \(0\)\
\-\ vancomycin\\ 1g\\ iv\\ q12\\,\\ ceftazidime\\ 2g\\ iv\\ q8\\,\\ and\ \(0\)\
\-\ metronidazole\\ 500\\ mg\\ iv\\ q6\ \(0\)\
\-\ axial\\ t2\\ fast\\ spin\\ echo\\ image\\ demonstrates\\ a\\ high\\ right\\ parietal\\ lobe\\ lesion\\ with\\ surrounding\\ vasogenic\\ edema\\.\\ \\ axial\\ diffusion\\-weighted\\ image\\ reveals\\ restricted\\ diffusion\\ in\\ the\\ lesion\\.\\ \\ sagittal\\ post\\-contrast\\ t1\\-weighted\\ mr\\ image\\ demonstrates\\ a\\ rim\\-enhancing\\ mass\\ with\\ surrounding\\ edema\\.\ \(0\)\
\-\ brain\\ abscess\ \(13\)\
\-\ \\"magic\\ dr\\"\ \(0\)\
\-\ 1\\.\\ metastatic\\ lesion\\:\\ carcinoma\\ and\\ sarcomas\\.\\ \\ must\\ also\\ consider\\ primary\\ tumors\\:\\ high\\ grade\\ glioma\\,\\ meningioma\\,\\ lymphoma\\,\\ leukemia\\,\\ pituitary\\ macrodenoma\\,\\ acoustic\\ \ \(0\)\
\-\ neuroma\\,\\ craniopharyngioma\\.\ \(1\)\
\-\ 2\\.\\ abscess\\:\\ bacterial\\,\\ fungal\\,\\ parasitic\\ and\\ empyema\\ \\(\\ epidural\\,\\ \\ subdural\\ \\)\ \(0\)\
\-\ 3\\.\\ glioma\ \(0\)\
\-\ 4\\.\\ infarct\\ \\(resolving\\ infarction\\,\\ \\ aging\\ hematoma\\,\\ \\ operative\\ bed\\ following\\ resection\\,\\ \\ thrombosed\\ aneurysm\\)\ \(0\)\
\-\ 5\\.\\ contusion\ \(0\)\
\-\ 6\\.\\ de\\-\\ myelinating\\ disease\\:\\ radiation\\ necrosis\\ and\\ necrotizing\\ leukoencephalopathy\\ with\\ methotrexate\ \(0\)\
\-\ 7\\.\\ resolving\\ hematoma\ \(0\)\
\-\ 75\\-year\\-old\\ woman\\ who\\ initially\\ presented\\ with\\ left\\-sided\\ weakness\\ and\\ headache\ \(1\)\
\-\ it\\ is\\ difficult\\ to\\ differentiate\\ various\\ types\\ of\\ abscesses\\ and\\ cystic\\ brain\\ tumors\\ such\\ as\\ high\\-grade\\ gliomas\\ and\\ metastases\\ with\\ conventional\\ imaging\\.\\ \\ \\ abscesses\\ typically\\ occur\\ more\\ frequently\\ in\\ the\\ first\\ 4\\ decades\\ of\\ life\\ with\\ a\\ triad\\ of\\ fever\\,\\ headache\\ \\(often\\ severe\\ and\\ on\\ the\\ side\\ of\\ the\\ abscess\\)\\,\\ and\\ focal\\ neurologic\\ deficit\\ in\\ about\\ \\ half\\ of\\ patients\\.\\ brain\\ abscesses\\ are\\ rare\\ in\\ immunocompetent\\ individuals\\ and\\ more\\ typically\\ seen\\ in\\ immunosuppressed\\ individuals\\,\\ such\\ as\\ patients\\ with\\ aids\\,\\ bone\\ marrow\\ and\\ solid\\ organ\\ transplants\\,\\ and\\ neutropenia\\.\\ \\ in\\ adults\\,\\ common\\ primary\\ sources\\ of\\ infection\\ include\\ ear\\ and\\ sinus\\ infections\\,\\ otitis\\ and\\ dental\\ abscesses\\.\\ \\ among\\ the\\ common\\ distant\\ foci\\ of\\ infection\\ are\\ hematogenous\\ spread\\ of\\ infection\\ from\\ a\\ distant\\ site\\ such\\ as\\ \\ pyogenic\\ lung\\ processes\\ and\\ endocarditis\\ \\.\\ \\ in\\ young\\ children\\ however\\,\\ bacterial\\ meningitis\\,\\ has\\ decreased\\ significantly\\ due\\ to\\ the\\ haemophilus\\ influenzae\\ vaccine\\.\\ \ \(0\)\
\-\ the\\ development\\ of\\ abscess\\ is\\ characterized\\ by\\ four\\ stage\\:\\ early\\ cerebritis\\,\\ late\\ cerebritis\\,\\ early\\ capsule\\ formation\\,\\ and\\ late\\ capsule\\ formation\\.\ \(0\)\
\-\ many\\ authorities\\ consider\\ mri\\ \\ imaging\\ has\\ the\\ advantage\\ over\\ ct\\ for\\ evaluating\\ the\\ early\\ cerebritis\\ stage\\ of\\ brain\\ abscesses\\.\\ \\ t1\\-weighted\\ images\\ enhance\\ the\\ abscess\\ capsule\\,\\ the\\ abscess\\ center\\ is\\ hypointense\\ and\\ after\\ gadolinium\\ there\\ is\\ enhancement\\ of\\ the\\ abscess\\ rim\\.\\ \\ on\\ t2\\-weighted\\ images\\ the\\ abscess\\ can\\ demonstrate\\ the\\ edema\\ zone\\ around\\ the\\ abscess\\.\\ \\ diffusion\\-weighted\\ \\ imaging\\ \\(dwi\\)\\ may\\ also\\ be\\ useful\\ in\\ distinguishing\\ abscesses\\ from\\ cystic\\ brain\\ tumors\\.\\ cerebral\\ abscess\\ will\\ usually\\ have\\ restricted\\ diffusion\\ and\\ is\\ hyperintense\\ on\\ diffusion\\-weighted\\ images\\,\\ \\ while\\ cystic\\ or\\ necrotic\\ tumor\\ typically\\ has\\ free\\ diffusion\\ and\\ is\\ hypointense\\ on\\ such\\ images\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ abscesses\\:\\ 0\\.0603316797175278\ \(0\)\
\-\ abscess\\:\\ 0\\.05628825508613056\ \(0\)\
\-\ diffusion\\-weighted\\:\\ 0\\.04070583331857783\ \(0\)\
\-\ cerebritis\\:\\ 0\\.03776831063579198\ \(0\)\
\-\ capsule\\:\\ 0\\.02891164801212545\ \(0\)\
\-\ brain\\:\\ 0\\.026784911701070436\ \(0\)\
\-\ diffusion\\:\\ 0\\.023906786482423514\ \(0\)\
\-\ resolving\\:\\ 0\\.022290760504861548\ \(0\)\
\-\ such\\:\\ 0\\.0222611065820071\ \(0\)\
\-\ individuals\\:\\ 0\\.020778654281155846\ \(0\)\
\-\ distant\\:\\ 0\\.020778654281155846\ \(0\)\
\-\ tumors\\:\\ 0\\.020060727235440633\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.01953493349550586\ \(0\)\
\-\ early\\:\\ 0\\.019532243560265238\ \(0\)\
\-\ iv\\:\\ 0\\.019490155859131837\ \(0\)\
\-\ consider\\:\\ 0\\.019338046475295252\ \(0\)\
\-\ typically\\:\\ 0\\.01885266105941233\ \(0\)\
\-\ late\\:\\ 0\\.018525294047914486\ \(0\)\
\-\ q8\\:\\ 0\\.018365663383263536\ \(0\)\
\-\ magic\\:\\ 0\\.018365663383263536\ \(0\)\
\-\ macrodenoma\\:\\ 0\\.018365663383263536\ \(0\)\
\-\ de\\-\\:\\ 0\\.018365663383263536\ \(0\)\
\-\ myelinating\\:\\ 0\\.018365663383263536\ \(0\)\
\-\ bacterial\\:\\ 0\\.01822027986448409\ \(0\)\
\-\ 1g\\:\\ 0\\.016921606757096985\ \(0\)\
\-\ 2g\\:\\ 0\\.016921606757096985\ \(0\)\
\-\ 75\\-year\\-old\\:\\ 0\\.016921606757096985\ \(0\)\
\-\ hypointense\\:\\ 0\\.016888935371536424\ \(0\)\
\-\ image\\:\\ 0\\.016682432289360005\ \(0\)\
\-\ restricted\\:\\ 0\\.01638631875575053\ \(0\)\
\-\ \\,\\:\\ 0\\.016355399791669445\ \(0\)\
\-\ q6\\:\\ 0\\.016076887781871642\ \(0\)\
\-\ influenzae\\:\\ 0\\.016076887781871642\ \(0\)\
\-\ authorities\\:\\ 0\\.016076887781871642\ \(0\)\
\-\ glioma\\:\\ 0\\.01605280747377746\ \(0\)\
\-\ infection\\:\\ 0\\.015525103587955044\ \(0\)\
\-\ q12\\:\\ 0\\.015477550130930433\ \(0\)\
\-\ ceftazidime\\:\\ 0\\.015477550130930433\ \(0\)\
\-\ immunosuppressed\\:\\ 0\\.015477550130930433\ \(0\)\
\-\ cystic\\:\\ 0\\.01540395442032349\ \(0\)\
\-\ stage\\:\\ 0\\.01518764345386811\ \(0\)\
\-\ edema\\:\\ 0\\.015105771808945567\ \(0\)\
\-\ immunocompetent\\:\\ 0\\.015012667732359162\ \(0\)\
\-\ haemophilus\\:\\ 0\\.015012667732359162\ \(0\)\
\-\ formation\\:\\ 0\\.014696880805299847\ \(0\)\
\-\ well\\-appearing\\:\\ 0\\.014311683906064968\ \(0\)\
\-\ rim\\-enhancing\\:\\ 0\\.014311683906064968\ \(0\)\
\-\ neutropenia\\:\\ 0\\.014311683906064968\ \(0\)\
\-\ transplants\\:\\ 0\\.01403349350476388\ \(0\)\
\-\ vaccine\\:\\ 0\\.01403349350476388\ \(0\)\
\-\ images\\:\\ 0\\.013660532432911284\ \(0\)\
\-\ 500\\:\\ 0\\.01356861110619261\ \(0\)\
\-\ aging\\:\\ 0\\.01356861110619261\ \(0\)\
\-\ neurologically\\:\\ 0\\.013370048231600266\ \(0\)\
\-\ metronidazole\\:\\ 0\\.013188774529538537\ \(0\)\
\-\ sarcomas\\:\\ 0\\.013022018888552003\ \(0\)\
\-\ advantage\\:\\ 0\\.013022018888552003\ \(0\)\
\-\ moved\\:\\ 0\\.012867627279898415\ \(0\)\
\-\ hematoma\\:\\ 0\\.012670695326758708\ \(0\)\
\-\ symmetrically\\:\\ 0\\.012589436878597326\ \(0\)\
\-\ neuroma\\:\\ 0\\.012589436878597326\ \(0\)\
\-\ imaging\\:\\ 0\\.012512961402847517\ \(0\)\
\-\ distinguishing\\:\\ 0\\.01246313558314642\ \(0\)\
\-\ leukoencephalopathy\\:\\ 0\\.012344055554313196\ \(0\)\
\-\ vancomycin\\:\\ 0\\.012231415510000121\ \(0\)\
\-\ sources\\:\\ 0\\.012231415510000121\ \(0\)\
\-\ headache\\:\\ 0\\.012229105989857492\ \(0\)\
\-\ were\\:\\ 0\\.012126789604312009\ \(0\)\
\-\ thrombosed\\:\\ 0\\.012124554480026056\ \(0\)\
\-\ high\\-grade\\:\\ 0\\.012124554480026056\ \(0\)\
\-\ endocarditis\\:\\ 0\\.012124554480026056\ \(0\)\
\-\ triad\\:\\ 0\\.012022908304673072\ \(0\)\
\-\ dr\\:\\ 0\\.011925991605433712\ \(0\)\
\-\ \\:\\:\\ 0\\.01177369599990276\ \(0\)\
\-\ gliomas\\:\\ 0\\.011744717903371983\ \(0\)\
\-\ surrounding\\:\\ 0\\.011704855268186522\ \(0\)\
\-\ otitis\\:\\ 0\\.011659672081454787\ \(0\)\
\-\ spin\\:\\ 0\\.011577962262385449\ \(0\)\
\-\ pyogenic\\:\\ 0\\.011577962262385449\ \(0\)\
\-\ hematogenous\\:\\ 0\\.011499336579087853\ \(0\)\
\-\ decades\\:\\ 0\\.011423570653731863\ \(0\)\
\-\ methotrexate\\:\\ 0\\.011350463737458382\ \(0\)\
\-\ fast\\:\\ 0\\.011279835504800714\ \(0\)\
\-\ post\\-contrast\\:\\ 0\\.011211523373919483\ \(0\)\
\-\ aids\\:\\ 0\\.011145380252430774\ \(0\)\
\-\ dental\\:\\ 0\\.011145380252430774\ \(0\)\
\-\ parasitic\\:\\ 0\\.011019078956979868\ \(0\)\
\-\ extraocular\\:\\ 0\\.010899998928146642\ \(0\)\
\-\ lesion\\:\\ 0\\.010878470162502842\ \(0\)\
\-\ empyema\\:\\ 0\\.010842917731921402\ \(0\)\
\-\ among\\:\\ 0\\.01057885167850652\ \(0\)\
\-\ primary\\:\\ 0\\.010547434428732069\ \(0\)\
\-\ differentiate\\:\\ 0\\.01048193497926716\ \(0\)\
\-\ organ\\:\\ 0\\.010435116529575373\ \(0\)\
\-\ necrotizing\\:\\ 0\\.010389327140577923\ \(0\)\
\-\ bed\\:\\ 0\\.010344522546367583\ \(0\)\
\-\ axial\\:\\ 0\\.010161631150282797\ \(0\)\
\-\ conventional\\:\\ 0\\.010094221896696618\ \(0\)\
\-\ has\\:\\ 0\\.010029374815589237\ \(0\)\
\-\ she\\:\\ 0\\.00999494225605905\ \(0\)\
\-\ acoustic\\:\\ 0\\.00997951402756531\ \(0\)\
\-\ evaluating\\:\\ 0\\.009906407111291832\ \(0\)\
\-\ various\\:\\ 0\\.009835778878634162\ \(0\)\
\-\ contusion\\:\\ 0\\.009801342832902472\ \(0\)\
\-\ mg\\:\\ 0\\.00976746674775293\ \(0\)\
\-\ high\\:\\ 0\\.009743941921153399\ \(0\)\
\-\ pupils\\:\\ 0\\.00973413270328118\ \(0\)\
\-\ necrotic\\:\\ 0\\.00973413270328118\ \(0\)\
\-\ movements\\:\\ 0\\.009669023237647626\ \(0\)\
\-\ vasogenic\\:\\ 0\\.009637216004041818\ \(0\)\
\-\ subdural\\:\\ 0\\.009637216004041818\ \(0\)\
\-\ processes\\:\\ 0\\.009637216004041818\ \(0\)\
\-\ operative\\:\\ 0\\.009605887092865693\ \(0\)\
\-\ 7\\.\\:\\ 0\\.00948508030609413\ \(0\)\
\-\ zone\\:\\ 0\\.009455942301980089\ \(0\)\
\-\ dwi\\:\\ 0\\.009455942301980089\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.00942720621420439\ \(0\)\
\-\ half\\:\\ 0\\.00939886110575485\ \(0\)\
\-\ common\\:\\ 0\\.00931778004981832\ \(0\)\
\-\ equal\\:\\ 0\\.009316068754401696\ \(0\)\
\-\ useful\\:\\ 0\\.009289186660993555\ \(0\)\
\-\ echo\\:\\ 0\\.009262647023957243\ \(0\)\
\-\ meningitis\\:\\ 0\\.009236441227692951\ \(0\)\
\-\ patients\\:\\ 0\\.009214894164025107\ \(0\)\
\-\ deficit\\:\\ 0\\.009184998284796344\ \(0\)\
\-\ field\\:\\ 0\\.009134795052339967\ \(0\)\
\-\ leukemia\\:\\ 0\\.009134795052339967\ \(0\)\
\-\ significantly\\:\\ 0\\.009110139932242045\ \(0\)\
\-\ types\\:\\ 0\\.009085773182735396\ \(0\)\
\-\ adults\\:\\ 0\\.009085773182735396\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.009014337612988248\ \(0\)\
\-\ pituitary\\:\\ 0\\.008922747772527587\ \(0\)\
\-\ more\\:\\ 0\\.008904901288800693\ \(0\)\
\-\ alert\\:\\ 0\\.008878419859095744\ \(0\)\
\-\ characterized\\:\\ 0\\.00885660465103888\ \(0\)\
\-\ epidural\\:\\ 0\\.00877155882912168\ \(0\)\
\-\ left\\-sided\\:\\ 0\\.00877155882912168\ \(0\)\
\-\ ear\\:\\ 0\\.00877155882912168\ \(0\)\
\-\ oriented\\:\\ 0\\.008730303355587972\ \(0\)\
\-\ center\\:\\ 0\\.008730303355587972\ \(0\)\
\-\ 6\\.\\:\\ 0\\.008650165270530065\ \(0\)\
\-\ fungal\\:\\ 0\\.008630603311467899\ \(0\)\
\-\ spread\\:\\ 0\\.008611223326754746\ \(0\)\
\-\ enhance\\:\\ 0\\.008611223326754746\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.00858228959159268\ \(0\)\
\-\ infections\\:\\ 0\\.008462350485125279\ \(0\)\
\-\ gadolinium\\:\\ 0\\.008444467685768212\ \(0\)\
\-\ reactive\\:\\ 0\\.008426737082293403\ \(0\)\
\-\ woman\\:\\ 0\\.00822459561453711\ \(0\)\
\-\ deficits\\:\\ 0\\.008146340928183476\ \(0\)\
\-\ must\\:\\ 0\\.008115703121121611\ \(0\)\
\-\ as\\:\\ 0\\.008078609411838298\ \(0\)\
\-\ visual\\:\\ 0\\.008070575002827488\ \(0\)\
\-\ in\\:\\ 0\\.00790119806512978\ \(0\)\
\-\ infarct\\:\\ 0\\.007899245631500462\ \(0\)\
\-\ and\\:\\ 0\\.007875394000784557\ \(0\)\
\-\ marrow\\:\\ 0\\.007831817955454562\ \(0\)\
\-\ difficult\\:\\ 0\\.007792384601526398\ \(0\)\
\-\ demonstrates\\:\\ 0\\.007777588340221608\ \(0\)\
\-\ life\\:\\ 0\\.007766504351529404\ \(0\)\
\-\ young\\:\\ 0\\.00775368379824945\ \(0\)\
\-\ development\\:\\ 0\\.00775368379824945\ \(0\)\
\-\ four\\:\\ 0\\.007728276979303995\ \(0\)\
\-\ frequently\\:\\ 0\\.007715688824187407\ \(0\)\
\-\ children\\:\\ 0\\.007690738426173415\ \(0\)\
\-\ 5\\.\\:\\ 0\\.007678374393840468\ \(0\)\
\-\ foci\\:\\ 0\\.007641716556568844\ \(0\)\
\-\ parietal\\:\\ 0\\.007605692604256217\ \(0\)\
\-\ metastases\\:\\ 0\\.007605692604256217\ \(0\)\
\-\ rim\\:\\ 0\\.007535461234793068\ \(0\)\
\-\ site\\:\\ 0\\.00752398278518688\ \(0\)\
\-\ distress\\:\\ 0\\.007501213888244818\ \(0\)\
\-\ neurologic\\:\\ 0\\.007434363232929192\ \(0\)\
\-\ around\\:\\ 0\\.007412548024872327\ \(0\)\
\-\ hyperintense\\:\\ 0\\.007390958885214937\ \(0\)\
\-\ free\\:\\ 0\\.007327502202955128\ \(0\)\
\-\ many\\:\\ 0\\.007317111491473797\ \(0\)\
\-\ infarction\\:\\ 0\\.00727605926005852\ \(0\)\
\-\ initially\\:\\ 0\\.007245792383885791\ \(0\)\
\-\ sagittal\\:\\ 0\\.007100722192721624\ \(0\)\
\-\ solid\\:\\ 0\\.007100722192721624\ \(0\)\
\-\ aneurysm\\:\\ 0\\.007036331489673547\ \(0\)\
\-\ is\\:\\ 0\\.0070286347298090706\ \(0\)\
\-\ necrosis\\:\\ 0\\.0070272931530098014\ \(0\)\
\-\ also\\:\\ 0\\.007019248306958964\ \(0\)\
\-\ 4\\.\\:\\ 0\\.007009333271668329\ \(0\)\
\-\ extremities\\:\\ 0\\.0069826804561268505\ \(0\)\
\-\ reveals\\:\\ 0\\.006965099479781299\ \(0\)\
\-\ rare\\:\\ 0\\.006913229580569367\ \(0\)\
\-\ about\\:\\ 0\\.006862619804383858\ \(0\)\
\-\ meningioma\\:\\ 0\\.006846019450948072\ \(0\)\
\-\ grade\\:\\ 0\\.006780909985314522\ \(0\)\
\-\ occur\\:\\ 0\\.006679263809961538\ \(0\)\
\-\ weakness\\:\\ 0\\.006611690318809134\ \(0\)\
\-\ intact\\:\\ 0\\.006539092961871285\ \(0\)\
\-\ sinus\\:\\ 0\\.0065107478534217455\ \(0\)\
\-\ side\\:\\ 0\\.006167596878675147\ \(0\)\
\-\ cerebral\\:\\ 0\\.006167596878675147\ \(0\)\
\-\ 3\\.\\:\\ 0\\.006091404608626515\ \(0\)\
\-\ on\\:\\ 0\\.006032425103045234\ \(0\)\
\-\ fever\\:\\ 0\\.006023463805316596\ \(0\)\
\-\ \\(\\:\\ 0\\.006019681052032171\ \(0\)\
\-\ first\\:\\ 0\\.005973923822470526\ \(0\)\
\-\ \\)\\:\\ 0\\.0059461474342775425\ \(0\)\
\-\ radiation\\:\\ 0\\.005842190103254867\ \(0\)\
\-\ revealed\\:\\ 0\\.005713487270554361\ \(0\)\
\-\ often\\:\\ 0\\.005680153226082609\ \(0\)\
\-\ 2\\.\\:\\ 0\\.005661341962083871\ \(0\)\
\-\ mr\\:\\ 0\\.005656665566555071\ \(0\)\
\-\ while\\:\\ 0\\.0056013525830256525\ \(0\)\
\-\ will\\:\\ 0\\.005569752121623212\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0055608107631200015\ \(0\)\
\-\ resection\\:\\ 0\\.005551907615667122\ \(0\)\
\-\ severe\\:\\ 0\\.005477728750137509\ \(0\)\
\-\ usually\\:\\ 0\\.0054061005288890815\ \(0\)\
\-\ decreased\\:\\ 0\\.005293242505676166\ \(0\)\
\-\ from\\:\\ 0\\.005276815471475885\ \(0\)\
\-\ lung\\:\\ 0\\.005156581500497388\ \(0\)\
\-\ lymphoma\\:\\ 0\\.005087913821644762\ \(0\)\
\-\ focal\\:\\ 0\\.005084361675288337\ \(0\)\
\-\ following\\:\\ 0\\.005052661993544059\ \(0\)\
\-\ carcinoma\\:\\ 0\\.005045682645866388\ \(0\)\
\-\ t2\\:\\ 0\\.005038726601563234\ \(0\)\
\-\ all\\:\\ 0\\.005035257269648523\ \(0\)\
\-\ include\\:\\ 0\\.004994069766729764\ \(0\)\
\-\ 4\\:\\ 0\\.004960358135789678\ \(0\)\
\-\ however\\:\\ 0\\.004957016782493897\ \(0\)\
\-\ are\\:\\ 0\\.004853641135540007\ \(0\)\
\-\ presented\\:\\ 0\\.0048528284062966855\ \(0\)\
\-\ lobe\\:\\ 0\\.004790261141507363\ \(0\)\
\-\ enhancement\\:\\ 0\\.004771851596089658\ \(0\)\
\-\ due\\:\\ 0\\.004750577401985082\ \(0\)\
\-\ who\\:\\ 0\\.004641600852378545\ \(0\)\
\-\ over\\:\\ 0\\.004532588729458255\ \(0\)\
\-\ metastatic\\:\\ 0\\.004481477924200188\ \(0\)\
\-\ bone\\:\\ 0\\.004423822253041396\ \(0\)\
\-\ acute\\:\\ 0\\.004395581935638532\ \(0\)\
\-\ the\\:\\ 0\\.004320290146988306\ \(0\)\
\-\ tumor\\:\\ 0\\.00415048396168919\ \(0\)\
\-\ demonstrate\\:\\ 0\\.004096775294443834\ \(0\)\
\-\ mri\\:\\ 0\\.004090158031072125\ \(0\)\
\-\ can\\:\\ 0\\.004037963234310562\ \(0\)\
\-\ it\\:\\ 0\\.004001767467777118\ \(0\)\
\-\ may\\:\\ 0\\.003904850768537758\ \(0\)\
\-\ have\\:\\ 0\\.0038550793299272743\ \(0\)\
\-\ after\\:\\ 0\\.0036833358387691716\ \(0\)\
\-\ no\\:\\ 0\\.0035851839612658417\ \(0\)\
\-\ seen\\:\\ 0\\.003517974198057688\ \(0\)\
\-\ a\\:\\ 0\\.003304998348488344\ \(0\)\
\-\ by\\:\\ 0\\.0029643143817601556\ \(0\)\
\-\ disease\\:\\ 0\\.002909869877532717\ \(0\)\
\-\ be\\:\\ 0\\.002745326506966519\ \(0\)\
\-\ of\\:\\ 0\\.0026698787682872347\ \(0\)\
\-\ there\\:\\ 0\\.0026494074093020596\ \(0\)\
\-\ ct\\:\\ 0\\.002490215944566756\ \(0\)\
\-\ mass\\:\\ 0\\.0024759604311407595\ \(0\)\
\-\ or\\:\\ 0\\.0020865057270077238\ \(0\)\
\-\ was\\:\\ 0\\.0020589115046118476\ \(0\)\
\-\ right\\:\\ 0\\.0018783993939800348\ \(0\)\
\-\ to\\:\\ 0\\.001779450451845776\ \(0\)\
\-\ with\\:\\ 0\\.001706310901310892\ \(0\)\
\-\ \\.\\:\\ 0\\.0017010194379978424\ \(0\)\
\-\ for\\:\\ 0\\.001518975309672323\ \(0\)\
